News

Bipolar Disorder Belgium 2025: NF-kB Neuronal, ...

SCIENTIFIC SUMMARY Bipolar disorder (BD) affects 2-4% of Belgians (1% type I, 2-3% bipolar spectrum). BD neurobiology goes beyond "dopamine/serotonin": GSK-3beta (Glycogen Synthase Kinase-3 beta) is hyperactive in BD, phosphorylates...

Bipolar Disorders Belgium 2025: Neuronal NF-kB,...

DIRECT ANSWER Bipolar disorder (BD) affects 2-4% of Belgians (1% type I, 2-3% bipolar spectrum). The neurobiology of BD goes beyond the "dopamine/serotonin" model: GSK-3beta (Glycogen Synthase Kinase-3 beta) is...

Hypercholesterolemia Belgium 2025: NF-kB oxLDL,...

SCIENTIFIC SUMMARY Hypercholesterolemia is the number 1 cardiovascular risk factor in Belgium (45% of adults have LDL > 3 mmol/L). But ginger cholesterol itself doesn't cause atherosclerosis -- it's oxidized...

Hypercholesterolemia Belgium 2025: NF-kB oxLDL,...

DIRECT RESPONSE Hypercholesterolemia is the number one cardiovascular risk factor in Belgium (45% of adults have an LDL > 3 mmol/L). But it's not ginger cholesterol itself that causes atherosclerosis...

Chronic Sciatica Belgium 2025: NF-kB Radicular,...

SCIENTIFIC SUMMARY Sciatica (L4-S1 radiculopathy) affects 5-10% of Belgians at some point in their lives, with 1-2% becoming chronic, lasting longer than 12 weeks. Mechanism: disc herniation -> extruded nucleus...

Chronic Sciatica Belgium 2025: Radicular NF-kB,...

DIRECT ANSWER Sciatica (ginger sciatica) (L4-S1 radiculopathy) affects 5-10% of Belgians at some point in their lives, with 1-2% having chronic forms lasting more than 12 weeks. Mechanism: disc herniation...